[1] |
陈品儒, 肖芃, 邓政先 , 等. 含头孢西丁药物方案治疗龟-脓肿分枝杆菌肺病的近期效果. 广东医学, 2014,35(11):1760-1764.
|
[2] |
陈品儒, 肖芃, 陈华 , 等. 非结核分枝杆菌肺病个体化治疗的疗效和安全性. 广东医学, 2012,33(11):1648-1651.
|
[3] |
陈品儒, 肖芃, 邓政先 , 等. 利奈唑胺联合治疗非结核分枝杆菌肺病的近期疗效与安全性. 现代医院, 2015,15(12):13-17.
|
[4] |
陈品儒, 谭守勇 . 快速生长分枝杆菌肺病21例的疗效分析. 中华结核和呼吸杂志, 2013,36(3):182-185.
|
[5] |
沙巍, 梁莉, 蒋瑞华 , 等. 含头孢西丁方案治疗高度耐药的快速生长型非结核分枝杆菌肺部感染16例疗效观察. 中华结核和呼吸杂志, 2011,34(4):265-268.
|
[6] |
中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2012,35(8):572-580.
|
[7] |
中国医师协会胸外科医师分会, “胸外科围手术期肺部并发症”研讨会. 胸外科围手术期肺部并发症防治专家共识. 中华胸心血管外科杂志, 2009,25(4):217-218.
|
[8] |
张亚楠, 段鸿飞 . 鸟-胞内分枝杆菌复合群肺病的诊断和治疗进展. 中国防痨杂志, 2017,39(10):1126-1129.
|
[9] |
何司琪, 陈品儒 . 快速生长分枝杆菌肺病94例临床分析. 中国防痨杂志, 2015,37(9):948-952.
|
[10] |
邓国防, 付亮, 唐怡敏 , 等. 277例非结核分枝杆菌肺病治疗状况分析. 中国防痨杂志, 2017,39(4):391-396.
|
[11] |
Moon SM, Park HY, Kim SY , et al. Clinical characteristics, treatment outcomes, and resistance mutations associated with macrolide-resistant Mycobacterium avium complex lung disease. Antimicrob Agents Chemother, 2016,60(11):6758-6765.
|
[12] |
Kadota T, Matsui H, Hirose T , et al. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. BMC Infect Dis, 2016,16:31.
|
[13] |
Ryu YJ, Koh WJ, Daley CL . Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians’ perspectives. Tuberc Respir Dis(Seoul), 2016,79(2):74-84.
|
[14] |
Lee MR, Sheng WH, Hung CC , et al. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis, 2015,21(9):1638-1646.
|
[15] |
Philley JV, Wallace RJ Jr, Benwill JL , et al. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest, 2015,148(2):499-506.
|
[16] |
Koh WJ, Hong G, Kim SY , et al. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. Antimicrob Agents Chemother, 2013,57(5):2281-2285.
|
[17] |
Winetsky DE, Myers J, Schulz S , et al. A case of cavitary pulmonary Mycobacterium avium intracellulare infection in the setting of leflunomide treatment. J Clin Rheumatol, 2017,23(4):231-232.
|
[18] |
沙巍 . 重视非结核分枝杆菌病的规范化诊治. 中国防痨杂志, 2017,39(3):217-219.
|
[19] |
Mitchell JD . Surgical approach to pulmonary nontuberculous mycobacterial infections. Clin Chest Med, 2015,36(1):117-122.
|
[20] |
黄朝林, 倪正义, 许俊 , 等. 外科治疗非结核分枝杆菌肺病的临床疗效分析. 临床肺科杂志, 2016,21(11):2092-2094.
|
[21] |
Haworth CS, Banks J, Capstick T , et al. British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). BMJ Open Respir Res, 2017,4(1):e000242.
|